According to Sientra's latest financial reports the company's current revenue (TTM) is $90.29 M.
In 2022 the company made a revenue of $90.54 M an increase over the years 2021 revenue that were of $80.68 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $90.29 M | -0.28% |
2022 | $90.54 M | 12.23% |
2021 | $80.68 M | 25.65% |
2020 | $64.21 M | -23.28% |
2019 | $83.69 M | 22.86% |
2018 | $68.12 M | 86.43% |
2017 | $36.54 M | 76.24% |
2016 | $20.73 M | -45.59% |
2015 | $38.1 M | -14.81% |
2014 | $44.73 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Edwards Lifesciences EW | $6.14 B | 6,703.40% | ๐บ๐ธ USA |
![]() iRadimed IRMD | $67.68 M | -25.04% | ๐บ๐ธ USA |
![]() Cardiovascular Systems CSII | $0.23 B | 165.61% | ๐บ๐ธ USA |
![]() West Pharmaceutical WST | $2.92 B | 3,143.23% | ๐บ๐ธ USA |